How should I evaluate and manage a patient with severe tricuspid regurgitation in the absence of atrial fibrillation?

Evaluation and Management of Severe Tricuspid Regurgitation Without Atrial Fibrillation

In patients with severe isolated tricuspid regurgitation (TR) without atrial fibrillation, surgery should be considered when symptoms develop or when right ventricular (RV) dilatation occurs, provided there is no severe RV/LV dysfunction or severe pulmonary hypertension. 1

Initial Diagnostic Evaluation

Echocardiographic Assessment

• Quantify TR severity using effective regurgitant orifice area (EROA), with EROA ≥0.40 cm² defining severe TR and predicting significantly worse outcomes (median survival 2.5 years vs. 8.5 years for EROA <0.40 cm²) 2
• Measure tricuspid annular diameter: annular dilation >40 mm or >21 mm/m² is a critical threshold for intervention 1
• Assess RV function and size: document RV dilatation and measure tricuspid annular plane systolic excursion (TAPSE) and TAPSE/RV systolic pressure ratio, as lower ratios predict mortality 2
• Evaluate for leaflet tethering: tethering height >8 mm predicts recurrent TR after repair 1
• Measure right atrial (RA) volume indexed: elevated RA volume independently predicts mortality 2

Hemodynamic and Functional Assessment

• Right heart catheterization may be needed to assess pulmonary pressures and exclude severe pulmonary hypertension, which increases surgical risk 1
• Look for physical examination findings: Carvallo sign (increased murmur with inspiration), pulsatile liver, and prominent jugular venous V waves are present in 88% of severe TR cases 3
• Assess for right-sided heart failure: peripheral edema, ascites, hepatic congestion, and elevated jugular venous pressure 1

Laboratory and Imaging Studies

• Serum albumin levels: lower albumin independently predicts 1-year mortality 2
• Liver function tests: Child-Pugh classification and MELD score to evaluate for hepatic dysfunction, as irreversible cirrhosis is a surgical contraindication 1
• Cardiac MRI: gold standard for RV evaluation, though underutilized in practice 4

Risk Stratification

Favorable Surgical Candidates (Class IIa Indication)

Patients with severe isolated secondary TR should undergo surgery if: 1

• Symptomatic with right-sided heart failure OR
• Asymptomatic with progressive RV dilatation
• Absence of severe RV dysfunction, severe LV dysfunction, or severe pulmonary vascular disease/hypertension

Primary TR Considerations

• Surgery may be considered (Class IIb) in asymptomatic patients with isolated severe primary TR and progressive RV dilation or systolic dysfunction 1

High-Risk Features Requiring Caution

• Severe irreversible RV dysfunction 1
• Advanced pulmonary hypertension 1
• Irreversible liver cirrhosis (absolute contraindication) 1
• Pre-operative TV tethering height >8 mm (predicts recurrent TR) 1

Management Algorithm

Medical Optimization (First-Line for All Patients)

• Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction if applicable 1
• Loop diuretics to relieve congestion and manage right-sided heart failure symptoms 1, 5
• Aldosterone antagonists for additional diuretic effect 1
• Optimize volume status carefully, as both under- and over-diuresis can worsen outcomes 5

Surgical Intervention Timing

Operate before irreversible damage occurs: 6

• Symptomatic severe isolated TR with low operative risk should undergo surgery prior to onset of RV dysfunction and end-organ damage
• Asymptomatic patients should be monitored closely for development of RV dilatation or dysfunction
• Average operative mortality is 8-10% for isolated TR surgery, making patient selection critical 6

Surgical Technique

• TV repair with prosthetic ring is first-line approach over replacement, offering better post-operative prognosis 1
• Repair is preferred to replacement when feasible, though there is risk of significant recurrent regurgitation 6
• Severe leaflet tethering may require additional techniques beyond annuloplasty alone to optimize long-term valve continence 4

Transcatheter Options

• Transcatheter TV intervention may be considered (Class IIb) in symptomatic patients with severe secondary TR who are inoperable, performed at centers with expertise in TV disease 1
• Novel percutaneous interventions may offer alternatives for high surgical risk patients, though further research is needed 6

Critical Pitfalls to Avoid

Common Misconceptions

• Do not assume functional TR will resolve spontaneously: traditional teaching that functional TR resolves with treatment of underlying disease has proven incorrect 7
• Do not delay surgery until severe RV dysfunction develops: outcomes worsen significantly once irreversible myocardial damage occurs 7, 6

Monitoring Considerations

• Stress echocardiography is rarely performed but may reveal dynamic changes in TR severity under physiological conditions 4
• The 5-grade TR classification based on objective quantitative parameters has not yet become common practice, leading to inconsistent severity assessment 4

Perioperative Management for Noncardiac Surgery

If noncardiac surgery is needed in patients with severe TR: 1

• Maintain sinus rhythm and optimize loading conditions with invasive hemodynamic monitoring
• Avoid hypotension and tachycardia through careful anesthetic management
• Consider intraoperative TEE or right-heart catheterization for continuous hemodynamic optimization